ArticleScientific reports2026
Explainable artificial intelligence for early Alzheimer's diagnosis using enhanced grey relational features and multimodal data.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Beyond Feature Selection: Interpretable Machine Learning for Mechanistic Insights in Metabolomics.Biology · 2026Review
- DPEA-Net: a clinically-oriented lightweight 3D CNN for glioma segmentation in multiparametric MRI.Frontiers in neurologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Alzheimer's disease, a progressive neurodegenerative disorder, presents a growing global health challenge due to its increasing prevalence and lack of accessible early diagnostic methods. Even though it has enhanced the diagnostic accuracy of machine learning, there is a major concern about striking a balance between predictive performance and interpretability. The proposed study presents an interpretable and sustainable machine learning architecture for early diagnosis of Alzheimer's disease based on multimodal, structured clinical and behavioral data, including demographics, vascular risk factors, lifestyle, and cognitive data. We perform extensive feature engineering to derive composite features, including blood pressure ratio, MMSE age ratio, cholesterol ratio, and cognitive decline score. The class imbalance is addressed using the Synthetic Minority Oversampling Technique. We also introduce a new strengthened Grey Relational Grade index based on the theory of grey system and the policy of sigmoid normalization. This greatly enhances the feature-diagnosis correlation (0.725 to 0.891), representing complicated nonlinear associations. This paper compared seven mainstream classifiers, such as Logistic Regression, Random Forest, Extreme Gradient Boosting, Light Gradient Boosting Machine, CatBoost, Stacking Ensembles, and Deep Neural Networks, in the context of model comparison. Among them, Deep Neural Networks achieve the best performance (accuracy: 98.01%, AUC: 99.43%), followed by a CatBoost-based Stacking Ensemble (Accuracy: 97.91%, AUC: 98.10%). Shapley Additive Explanations make models easier to understand by showing important modifiable predictors like family history, smoking, and early cognitive symptoms. This study presents that combining enhanced Grey Relational Grade metrics with robust machine learning and deep learning models produces an accurate, interpretable, and potentially effective framework for early AD risk assessment, which can be used to implement effective, behavior-centric prevention strategies in ageing demographics.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.